Ligand Pharmaceuticals Incorporated · La Jolla, CA United States (NASDAQ: LGND)
| 11085 N. Torrey Pines Rd., Ste. 300 | Phone: 858-550-7500 |
| La Jolla, CA | Fax: 858-550-7506 |
| 92037 | |
| United States | 
Map This Company |
Ligand Pharmaceuticals Incorporated Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Ligand Pharmaceuticals seeks to discover disease-curing molecules. The drug development company works with gene transcription technology to address assorted illnesses. Its research and development projects include treatments for thrombocytopenia (low platelet count), osteoporosis, Alzheimer's disease, hepatitis C, cancers, cardiovascular ailments, arthritis, asthma, and diabetes. Ligand Pharmaceuticals conducts many of its programs through partnerships with other drugmakers. The company is focused on expanding its development pipeline through additional partnerships, as well as via acquisitions.
Ligand Pharmaceuticals Incorporated Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: LGND Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 31 |
Executives
24 executives listed for Ligand Pharmaceuticals Incorporated's La Jolla, CA location.
| Chairman | John Kozarich | |
|---|---|---|
| President, CEO, and Director | John Higgins | |
| VP Finance and CFO | John Sharp |